| AAT | Alpha-1-ntitrypsin |
| 2DE | Two-dimensional gel electrophoresis |
| ABL1 | Tyrosine-protein kinase ABL1 |
| ACK-1 | Activated CDC42 kinase 1 |
| AKT | Protein kinase B |
| ALOX5 | Arachidonate 5-lipoxygenase |
| ANXA2 | Annexin A2 |
| ATP | Adenosine triphosphate |
| BCAR3 | Breast cancer anti-estrogen resistance protein 3 |
| Bcl-2 | B-cell lymphoma 2 |
| BIM | B cell lymphoma-2-like 11 |
| c-MET | Tyrosine-protein kinase Met |
| C797S | The mutation substitutes a cysteine with a serine at position 797 |
| CAF | Cancer-associated fibroblast |
| CASL | Integrin signaling adaptor |
| CDH1 | Epithelial cadherin |
| CNS | Central nervous system |
| E-cadherin | Epithelial cadherin |
| EGFR | Epidermal growth factor receptor |
| eIF3c | Eukaryotic Translation Initiation Factor 3 Subunit C |
| EMT | Epithelial to mesenchymal transition |
| EPHB1 | EPH receptor B1 |
| ERAP | Endoplasmic reticulum aminopeptidase |
| ErbB | A family of proteins contains four receptor tyrosine kinases |
| ERK | Extracellular signal-regulated kinase |
| exon 19 delins | Exon 19 deletion-insertions |
| exon 19dels | Exon 19-microdeletions |
| FAK | Focal adhesion kinase |
| FGA2 | Isoform 2 of fibrinogen alpha chain |
| FGFR | Fibroblast growth factor receptor 1 protein |
| FOXM1 | Forkhead box protein M1 |
| FRS-2 | Fibroblast growth factor receptor substrate 2 |
| HER1 | Human epidermal growth factor receptor 1 |
| HER2 | Human epidermal growth factor receptor 2 |
| HER4 | Human epidermal growth factor receptor 4 |
| HGF | Hepatocyte growth factor |
| HLA | Human leukocyte antigen |
| HMGA2 | High-mobility group AT-hook 2 |
| IGF | Insulin-like growth factor |
| IGFR2 | Insulin-like growth factor 2 receptor |
| IL-6 | Interleukin-6 |
| IRS2 | Insulin receptor substrate 2 |
| ITGAV | Integrin alpha V |
| iTRAQ | Isobaric tags for relative and absolute quantitation |
| L858R | The mutation substitutes a leucine with an arginine at position 858 |
| LAMA5 | Laminin α5 |
| LOXL2 | Lysyl oxidase homolog 2 |
| MALDI-TOF | Matrix-Assisted Laser Desorption/Ionization Time-of-Flight |
| MAPK | Mitogen-activated protein kinase |
| MID1 | A protein that belongs to the Tripartite motif family |
| mOS | Median overall survival |
| mPFS | Median progression-free survival |
| mTOR | Mammalian target of rapamycin |
| NNMT | Nicotinamide N-methyltransferase |
| OPN | Osteopontin |
| ORR | Objective response rate |
| PBC | Platinum-based chemotherapy |
| PD | Progressive disease |
| PE | Pleural effusion |
| PFS | Progression-free survival |
| PI3K | Phosphoinositide 3-kinase |
| PRAS40 | Proline-rich Akt substrate of 40 kDa |
| PR | Partial response |
| PTPN11 | Tyrosine-protein phosphatase non-receptor type 11 |
| RGD | Arginine-glycine-aspartic acid |
| RPPA | Reverse Phase Protein Array |
| RTK | Receptor tyrosine kinase |
| SAC | Spindle assembly checkpoint |
| sCDH3 | Soluble cadherin-3 |
| SFK | Src family kinases are composed of 10 proteins: Src, Frk, Lck, Lyn, Blk, Hck, Fyn, Yrk, Fgr, and Yes |
| SILAC | Stable isotope labeling by amino acids in cell culture |
| SIRT1 | Sirtuin 1 |
| SLC1A5 | Solute carrier family 1 member 5 |
| SSA1 | Serum amyloid A protein 1 |
| T790M | The mutation substitutes a threonine with a methionine at position 790 |
| TAP1 | Transporter associated with antigen processing 1 |
| TKI | Tyrosine kinase inhibitor |
| VCL | Vinculin |
| WNK1 | Lysine deficient protein kinase 1 |
| YAP | Yes-associated protein |
| ZEB1 | Zinc Finger E-Box Binding Homeobox 1 |